India Glycols Limited has announced a physical group meeting with analysts and institutional investors scheduled for September 2, 2026. The event will take place in Mumbai starting at 5:00 pm IST.

The company issued the disclosure on August 28, 2026, pursuant to Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015. The notice was communicated to the listing managers at both the Bombay Stock Exchange and the National Stock Exchange of India.

Meeting Details

The interaction is structured as a physical group meeting. Participants should note that the schedule is subject to change due to exigencies on the part of the participants, host, or company.

Scope of Discussion

The company explicitly stated that discussions during the interaction will be based solely on publicly available information. No unpublished price-sensitive information (UPSI) is intended to be discussed.

Ankur Jain, Head (Legal) & Company Secretary, signed the disclosure. The notice is also hosted on the company’s official website for public record.

India Glycols has fixed September 1, 2026, as the effective date for its approved demerger scheme. The company also announced September 2, 2026, as the record date for allotting shares to existing shareholders. Both resulting entities, Ennature Bio Pharma Limited and IGL Spirits Limited, have finalized their respective boards of directors.

The Board of Directors passed a resolution by circulation on August 21, 2026, finalizing these dates. This follows the receipt of the certified true copy of the National Company Law Tribunal order on August 20, 2026. The Allahabad Bench of the NCLT had sanctioned the arrangement on July 17, 2026.

Scheme Structure and Share Ratios

The approved scheme involves the demerger of India Glycols Limited into Ennature Bio Pharma Limited and IGL Spirits Limited. The appointed date for the transaction remains April 1, 2026.

Existing equity shares held by India Glycols in the resulting companies will be cancelled once the scheme becomes effective. The remaining business, assets, and liabilities will continue to vest with India Glycols Limited.

New Board Appointments at Ennature Bio Pharma

On August 21, 2026, the Board of Ennature Bio Pharma Limited approved the following appointments, subject to shareholder approval:

• Ms. Pragya Bhartia Barwale: Managing Director and Key Managerial Personnel for five years. She holds a BA from Brown University and an MSc from Oxford University. She has over 18 years of experience and led the Ennature Biopharma division to revenue exceeding ₹200 crore.
• Mr. U.S. Bhartia: Additional Director (Non-Executive). He is related to Ms. Pragya Bhartia Barwale as father.
• Ms. Pooja Jhaver: Additional Director (Non-Executive). She holds degrees from St. Stephen's College and Oxford University. She is related to Mr. U.S. Bhartia as daughter.
• Mr. Malay Memani: Independent Director for three years. He leads Autometers Energitec Limited and holds an MSc from London Business School.
• Ms. Shukla Wassan: Independent Director for three years. She has over 30 years of experience in corporate law and governance.
• Ms. Bharati Agarwal: Independent Director for three years. Former Managing Director at TPG NewQuest, she holds an MBA from IIM Ahmedabad.
• Ms. Shilpa Divekar Nirula: Independent Director for three years. Former CEO of Monsanto India, she holds an MBA from SP Jain Institute.

New Board Appointments at IGL Spirits

On August 21, 2026, the Board of IGL Spirits Limited approved the following appointments, subject to shareholder approval:

• Mr. U.S. Bhartia: Chairman and Managing Director (Key Managerial Personnel) for five years. He holds a commerce degree with honours from Kolkata University and has over four decades of business management experience.
• Mr. Vedant Jhaver: Additional Director (Non-Executive). He holds a master's degree in computer science engineering and business management from Cornell University. He is related to Mr. U.S. Bhartia as son-in-law.
• Mr. Shirish Rajendra Barwale: Additional Director (Non-Executive). He holds degrees from Cornell University and London School of Economics. He is related to Mr. U.S. Bhartia as son-in-law.
• Mr. Samrat Banerjee: Independent Director for three years. He holds a master's in economics from Delhi School of Economics and has approximately three decades of experience managing multi-asset class portfolios.
• Mr. Raj Kishore Singh: Independent Director for three years. He holds a bachelor's degree in technology (mechanical engineering) from Banaras Hindu University and has over 40 years of experience in the Oil & Gas sector.
• Mr. Vimal Bhandari: Independent Director for three years. He is a Chartered Accountant with over 40 years of experience in financial services.
• Ms. Nidhi Jagat Killawala: Independent Director for three years. She is a Partner at Khaitan & Co. LLP with over 13 years of experience in corporate transactions.

Regulatory and Tax Implications

The NCLT order mandates that all rights, benefits, interests, and obligations related to the respective undertakings transfer to the new entities as a going concern. This includes the transfer of pending legal proceedings and tax liabilities associated with each specific undertaking.

The Income Tax Department is permitted to retain recourse for recovery regarding demands and future liabilities of the demerged company in respect of assets transferred under the scheme. The petitioner companies must file modified income tax returns under Section 314(1) of the Income Tax Act, 2025, within six months from the end of the month of the order.

Shareholder Approval Context

The tribunal noted that the scheme had already secured requisite majority approvals prior to this final sanction. Equity shareholders of the demerged company voted overwhelmingly in favor, with 4,42,48,625 votes cast in support out of 4,42,48,626 total votes, representing only one vote against. Unsecured creditors also provided unanimous consent, with 36 out of 36 participating creditors voting in favor by value.